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Abstract 
Depression is a disorder frequently noted in college students that can affect 
multiple aspects of one's life, ranging from physical health issues to interpersonal 
relationship difficulties. Therefore, it is imperative that the depressive symptoms of 
college students be identified, evaluated, and treated. This investigation explored the 
validity of a newly published self-report narrow-band measure of depression, the Clinical 
Assessment of Depression (CAD; Bracken & Howell, 2004) with an existing broad-band 
measure, the Brief Symptom Inventory (Derogatis, 1993). College students 18 to 52 years 
of age (n = 280) enrolled in undergraduate courses in psychology at a south central 
Kentucky university provided the study data. Strong positive correlations (.60 to 1.0) 
supported convergent validity between three of the five scales on the CAD with the BSI 
Global Severity Index. Moderate level correlations (.20 to .60) between dissimilar scales 
supported divergent validity between the two measures. The correlations between the 
measures generally supported stronger relationships between scales of similar symptom 
patterns. Acceptable classification consistency (80%) existed between the two measures 
using the BSI Global Severity Index at or above a T score of 63 and the CAD two 
standard deviations above the mean classification criterion (T > 70). The combination of 
the two criterion resulted in acceptable classification consistency for all CAD scales with 
iv 
the BSI Somatization, Depression and Anxiety Scales. This study also investigated 
gender differences. Independent /-tests evidenced no mean score differences based on 
gender for the CAD Total score. Results support the use of the CAD as an adequate 
diagnostic tool for depression with college students. A discussion of implications for use 
of the CAD provides guides for practice and suggestions for further research. 
v 
Introduction 
Depression is a disorder that affects 19 million adults annually with most 
individuals experiencing their first depressive episode between the ages of 15 and 19, 
corresponding with the age when most students are adjusting to college life (National 
Center on Addiction and Substance Abuse at Columbia University [CASA], 2003). New 
life stressors such as those experienced by college students may lead some to become 
depressed. Close to 40 percent of college students report feeling frequently 
overwhelmed, and 53 percent experience some depression before graduating (CASA, 
2003). Depression creates serious functional impairments and risks for college students 
including suicide, the second leading cause of death in this age group. 
Assessment of psychological disorders, such as depression, involves multiple 
methods including standardized instruments and diagnostic interviews. In order to 
determine the effectiveness of new standardized measures, it is important to compare 
them to existing measures. The Clinical Assessment of Depression (CAD; Bracken & 
Howell, 2004) is a new measure that attempts to assess depression across the lifespan. Of 
interest in this study will be the CAD's ability to assess and identify college age 
individuals' symptoms of depression relative to an existing measure of depression, the 
Brief Symptom Inventory- 4th edition (Derogatis, 1993). 
The following literature review will provide a rationale and purpose for the 
investigation of the CAD. The first section provides a general discussion of depression 
including the diagnostic criteria along with a discussion of the features of depression and 
factors influencing prevalence. The next section provides an overview of depression in 
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college students. The CAD and a rationale for the selection of the criterion measure, the 
Brief Symptom Inventory- 4th edition, will be discussed (BSI; Derogatis, 1993). Next, a 
discussion of the present study including the results and implications is provided. 
Literature Review 
Disruption in mood is the predominant symptom used to categorize a group of 
psychological disorders within the mood disorders classification. These mood disorders 
are divided into unipolar disorders and bipolar disorders. While both involve the 
experience of some form of a depressed mood, the focus of this discussion will be on the 
unipolar depressive disorders: major depression, dysthymic disorder, and depressive 
disorder not otherwise specified. 
Diagnostic Criteria 
Mental health professionals diagnose mood disorders using the criterion 
established in the Diagnostic and Statistical Manual of Mental Disorders - 4th Edition, 
Text Revision (DSM-IV-TR; American Psychiatric Association [APA], 2000). A major 
depressive episode is defined as, "a period of time lasting at least two weeks in which an 
individual experiences a depressed mood or a loss of interest or pleasure in nearly all 
activities" (APA, 2000, p. 349). 
To be diagnosed with major depression under the DSM-IV-TR, a patient must 
exhibit at least five of the following symptoms: (a) depressed mood, (b) diminished 
interest or pleasure in activities, (c) significant change in weight and/or appetite, (d) 
changes in sleep , (e) psychomotor agitation or retardation, (f) decreased energy, (g) 
feelings of worthlessness or guilt, (h) inability to concentrate or make decisions, or (i) 
frequent thoughts of death and suicide ideation (APA, 2000). These symptoms are 
considered serious and debilitating when they detrimentally affect an individual's social, 
occupational, or other functioning. The DSM-IV-TR goes on to note that in young adults 
"the mood may be irritable rather than sad" (APA, 2000, p. 349). 
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Dysthymic disorder is a milder variant of major depression, and individuals 
evidence a chronically depressed mood sustained over a two-year period. In addition, 
there must be at least two additional symptoms from the following: (a) poor appetite or 
overeating, (b) insomnia or hypersomnia, (c) low energy or fatigue, (d) low self-esteem, 
(e) poor concentration or difficulty making decisions, and (f) feelings of hopelessness 
(APA, 2000). Symptom free periods must not last longer than 2 months during the 2-year 
period, and there is no evidence of a major depressive episode. 
Depressive disorder not otherwise specified includes symptom patterns that have 
depressive features but do not meet the criteria for major depressive disorder or 
dysthymic disorder. Individuals may experience fewer symptoms than required by the 
other two disorders, and/or the duration of symptoms may be briefer. When symptom 
patterns are difficult to distinguish, this is the diagnosis given (APA, 2000). 
Individuals experiencing depression often exhibit specific behavioral indicators, 
e.g., reduced activity, slowed speech, and social withdrawal (Mash & Wolfe, 2000). 
Adolescents may express their sadness through negative behaviors such as verbal 
sarcasm or destructive behavior. Individuals experiencing depression often become 
preoccupied with their personal thoughts, may evidence distorted reasoning, brooding, 
and often have difficulty concentrating, remembering, and making decisions. Depression 
creates serious risks including possible suicide, which is the second leading cause of 
death for young adults (CASA, 2003). 
Major depression, dysthymia, and depressive disorder not otherwise specified 
have common symptom patterns that may differ in number, severity, and duration. Of 
importance for this discussion is the cluster of symptoms and associated features that 
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encompass the experience of depression and lead to the behavioral diagnosis of one of the 
mood disorders. In this section of the paper, the generic term depression refers to 
patients' symptom patterns. 
Comorbidity 
Depression often appears in association with other psychological disorders 
(Parker & Roy, 2001). Estimates of comorbidity rates are as high as 40 to 95 percent. 
Anxiety disorders represent the most common comorbid disorders with depression. For 
example, anxiety precedes the onset of depression in 85 percent of comorbid cases 
(Koplewicz, 2002). Due to this high rate of comorbidity, diagnosticians often encounter 
difficulties when trying to distinguish between the two conditions (Nitschke, Heller, 
Imig, McDonald, & Miller, 2001). Furthermore, the symptoms associated with the two 
disorders overlap and often cause confusion in the assessment process. Symptoms of 
anxiety disorders can include: (a) chronic exaggerated worry and tension, (b) almost 
constant anticipation of disaster, (c) repeated, intrusive and unwanted thoughts or, (d) 
physical symptoms such as trembling, muscle tension, headache, and nausea (Mash 
&Wolfe, 2005). The two disorders have overlapping symptoms such as concentration 
difficulties and sleep disturbances. Other common symptoms include distorted thinking 
and somatic complaints. 
There are many reasons for this high comorbidity between anxiety and depression 
such as stressful life events or similar biological causes. Stressful events that trigger 
anxiety disorders are more likely to cause depression (Mineka, Watson, & Clark, 1998). 
Twenty-five to 50 percent of depressed young adults also experience symptoms of 
anxiety. Alternatively, only 10 to 15 percent of young adults with anxiety disorders will 
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experience symptoms of depression (Alansari, 2005). In fact, anxiety disorders may 
prove to be a strong predictor of subsequent depression. According to Lepine, 
Wittchen, and Essau (1993), 83 percent of individuals with comorbid anxiety and 
depression reported that anxiety was their initial disorder. While all anxiety disorders are 
associated with higher rates of depression, disorders including obsessive-compulsive 
disorder, panic disorder, agoraphobia, and post-traumatic stress disorder are the most 
highly associated with subsequent episodes of Major Depressive Disorder (Mineka et al., 
1998). 
Depression can be difficult to distinguish from anxiety. Therefore, it is essential 
that measures correctly identify individuals experiencing depression in order to develop 
appropriate treatment strategies. 
Factors Contributing to Depression 
Depression develops from multiple factors. Childhood experiences, family 
relationships, and genetic predisposition can make an individual more susceptible to 
depression (Slavik & Croake, 2006). Diathesis-stress models of depression explain the 
apparent susceptibility of some individuals to depression (Slavik & Croake, 2006). These 
models acknowledge the impact that stressful life events and underlying vulnerabilities 
have on an individual's development of depression. Diathesis-stress models propose that 
depression develops within the context of significant life stressors in combination with an 
individual vulnerability to develop depression. Factors that can predispose an individual 
to develop depression include genetics, family environment, and cognitive style. 
Genetics. Parker and Roy (2001) describe several factors that can influence an 
individual's risk of developing depression including genetics, family environment, 
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stressful events, and behavioral/emotional issues. Often multiple factors will come into 
play and may lead to different approaches to treatment and intervention. Genetic factors, 
however, represent the dominant predictor of depression in young adults (Parker & Roy, 
2001). Risks of comorbidity with anxiety increase when both a parent and a grandparent 
have had depressive episodes. Twin and adoption studies indicate that genetic factors are 
the reason for 50% of the variance in occurrence of mood disorders (Parker & Roy, 
2001). Similarly, first-degree relatives (parents, siblings, or children) evidence 
prevalence rates between 20 to 46% (Williamson et al., 1995). Genetic factors play a roll 
in an individual's susceptibility to depression; however, other factors can also lead to an 
increase in the probability of the onset of the disorder. 
Family Environment. Although genetic factors contribute to the development of 
depression, it is not the only influential factor (Parker & Roy, 2001). Family 
environments also influence whether young adults will develop depression. The actions 
of parents themselves also affect a child's susceptibility to depression (Parker & Roy, 
2001). Parents can engage in behaviors that lead children to be less resilient and more 
likely to suffer from depression. Families that do not provide social support or do not 
provide the opportunity for support outside of the family are associated with the onset of 
depression in young adults or adolescents (Ostrander, Weinfurt, & Nay, 1998). 
Depressed individuals often perceive their families as having conflict and being 
unsupportive. Individuals in homes with family conflict are more likely to suffer from 
recurring depression (Parker & Roy, 2001). Mash and Wolfe (2005) in their review of 
family influences on the development of depression also note poor relationships with 
peers along with poor relationships with siblings and parents. Mash and Wolfe further 
10 
interpret these negative relationships to influence the child's environment to the point that 
parents and siblings may respond in ways that are negative, dismissing, or harsh to the 
child experiencing depression. In addition, families of individuals experiencing 
depression displayed less effective communication, less warmth and support, and more 
anger and over involvement than families of children who are not depressed. These 
interactional patterns worsen the stressors for the child experiencing depression. Further, 
the studies reviewed by Mash and Wolfe (2005) indicated that depression in the child or 
parent interferes with the parent's ability to meet the needs of the child. Thus the family 
influences are both bidirectional and interactive in nature. Individuals who have 
experienced early stress or difficult family lives may not have developed appropriate 
coping mechanisms and will not handle stress appropriately in later life, making them 
more susceptible particularly if they have a genetic predisposition for depression (Slavik 
& Croake, 2006). 
Cognitive Style. Attribution style influences behavioral and emotional factors 
related to depression (Parker & Roy, 2001). Individuals with internalizing attributions, 
meaning individuals who attribute events or actions outside of personal control to their 
internal personal attributes (e.g., intelligence), are often at higher risk to become 
depressed. These individuals often exhibit anxious behaviors along with depression. 
Externalizing individuals, those that attribute circumstances to factors outside of their 
own control often experience feelings of helplessness are more likely to struggle with 
conduct disorders and substance abuse problems. 
The cognitive diathesis stress model looks at individuals' susceptibility to 
depression and relates it to the way in which they think of themselves and the world 
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(Slavick & Croake, 2006). Individuals with consistent negative thoughts about 
themselves and the world may appraise events and situations differently than someone 
who does not, therefore events may be more difficult for one than another. People who 
tend to make these types of cognitive errors are particularly vulnerable to depression 
when exposed to stressful events (Ostrander, Weinfurt, & Nay, 1998). The Interactive 
Stress Diathesis model notes that deficiencies in coping methods and interpersonal skills 
may lead individuals to either be unable to forestall stress or to provoke the situations that 
create it, resulting in depression (Slavick & Croake, 2006). 
Ethnicity, Gender and Age 
Ethnicity. Ethnicity is an important factor to consider in the identification of 
individuals experiencing depression and can influence the timelines of treatment for 
minorities (Simpson, Krishnan, Kunik, & Ruiz, 2006). According to Simpson et al. 
(2006), multiple studies indicate less frequent identification of Blacks and Hispanics as 
experiencing depression. While depression diagnosis rates are not as high in minority 
populations, it continues to be of concern. Hispanic adolescents evidence higher rates of 
suicidal ideations than their White counterparts do (Gutierrez, Rodriguez, & Garcia, 
2001). While African-American college students are less likely than White students to 
engage in suicidal ideation and attempts, suicide completion rates among Black college 
students increased 126% from 1980 to 1995 (Gutierrez et al., 2001). 
Bromberger, Harlow, Avis, Kravitz, and Cordal (2004) found that depression 
rates were highest in African-American and Hispanic women. Prevalence rates within 
their sample were as follows: (a) White, 22.29% (b) Black, 27.44%, (c) Hispanic, 
42.97%, (d) Chinese, 14.39%, and, (e) Japanese, 14.32%. However, depressive 
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symptoms are similar across ethnic groups when the studies control for socioeconomic 
factors. Overall, Bromberger, et al. (2004) found that variability in the prevalence of 
depressive symptoms by ethnicity is largely a function of socioeconomic status due to 
increased stress and health-related factors. 
Gender. Women face a greater risk than men of experiencing a depressive 
disorder (Kuehner, 2003). Mean sex ratios are equivalent in preadolescence but have 
been found to diverge to ratios of 2:1 to 3:1 after puberty (Mash & Wolfe, 2005). The 
typical symptoms of depression may be displayed differently in men and women 
(Piccinelli & Wilkinson, 2004). Women more often report changes in appetite, 
interruptions or increase in sleep, fatigue, anxiety and hypochondriasis. Kuehner (2003) 
found that differences in the course of the illness do not account for the difference in 
prevalence rate. However, Hicks (2005) examined mean differences between men and 
women of college age and found no significant differences based on gender. 
Cross-cultural studies indicate that depression rates in women vary related to 
control of resources, marriage patterns, and cultural beliefs (Norman, 2004). Norman 
(2004) presents two explanations for the higher prevalence of depression in women: the 
physiology of reproduction such as hormonal variation and women's roles and status. 
Women's role in society, such as subservience, leads to a sense of helplessness and 
creates an increased susceptibility to stress and depression (Norman, 2004). Norman 
(2004) further notes that the consistency of the gender ratio in prevalence rates lends 
strength to the physiological explanation. However, physiological explanations do not 
account for poverty rates or other cultural factors. Moreover, the increasing urbanization 
of developing countries has lead to an increase in prevalence rates of co-occurring 
depression and anxiety for women. 
Not only are women more likely to experience depressive symptoms, other 
findings support that their symptoms will be of greater severity than those of males 
(Baron & Campbell, 1993). In a study comparing female and male mean scores on the 
Reynolds Adolescent Depression Scale (RADS) and the Beck Depression Inventory 
(BDI), Baron and Campbell (1993) found that females have higher mean scores on 
discriminating items. These gender differences of rating may be due to factors such as 
physiology, societal roles, and environmental stress. Therefore, not only are women more 
susceptible to depression due to social roles and biological factors, but diagnostic tools 
are more likely to identify them as depressed. 
Depression in College Populations. Without treatment, depression can have a 
debilitating effect on many different facets of an individual's life (Mufson, Pollack-
Dorta, Moreau, & Weissman, 2004). For example, individuals experiencing depression 
often suffer in their personal, social, and academic lives. Moreover, the diagnosis of 
depression in college students is often confounded because they present symptoms 
associated with both adults and adolescents. For example, while anhedonia, the inability 
to experience pleasure, is a common symptom in adult depression, it is not always present 
in younger populations including college students. College students also may exhibit over 
reaction to external stressors and exhibit irritability rather than depressed mood, which is 
symptomology commonly associated with children rather than adults (Mufson et al., 
2004). 
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College students' experiences of depression often manifest in several ways. 
While most adults experiencing depression suffer from an all encompassing, long lasting 
depression, young adults may experience periods of depression interspersed with periods 
of relative normalcy (Mufson, et al., 2004). The duration of most depressive episodes in 
young adults is seven to nine months with 90 percent of the episodes ending within a one 
to two year period of time (Parker & Roy, 2001). Parker and Roy (2001) note that single 
episodes frequently subside within one year, however, 40 percent of depressed young 
adults will experience another episode within two years and 70 percent will experience a 
relapse within the next five years. 
Although suicide represents the most severe consequence of depression, 
depression also affects other aspects of student success causing students to struggle in 
other areas of their college lives. For example, depression can negatively affect a 
student's GPA and ability to concentrate (CASA, 2003). Students with major depressive 
disorder perform more poorly on standardized tests, are rated by their teachers as doing 
less well academically, and have lower achievement scores (Mash & Wolfe, 2005). 
Depression may also be associated with a decrease in cognitive ability. Kovacs and 
Goldston (1991) found that depression might be associated with impairments on 
nonverbal tasks, which require attention, coordination, and speed. Furthermore, students 
experiencing depression are more likely to engage in behavior detrimental to their 
academic success such as skipping class or failing to complete assignments (CASA, 
2003). 
Academic performance is not the only aspect of a student's college life affected 
by depression. Research indicates that students dealing with depression are more likely to 
15 
engage in unnecessarily risky behavior like substance use and abuse (CASA, 2003). 
Estimates of comorbidity rates for depression and substance abuse are as high as 51 
percent (Subramaniam, Lewis, Stitzer, & Fishman, 2004). Moreover, depressed students 
are more likely to participate in sexually risky behavior, and they face a higher risk for 
sexually transmitted disease (CASA, 2003). Students experiencing depression are also 
more likely to become physically ill and experience body pain, allergies, cold symptoms, 
nausea, and headaches (CASA, 2003). Thus, depression is a disorder that affects college 
students and can have severe implications. 
Measurement Issues 
Depression is an ongoing concern on college campuses. With 40% of college 
students experiencing depression that affects their academic performance and emotional 
well-being, it is essential that effective identification tools are available. To accurately 
diagnose depression in students, diagnosticians need quality measures. Gender 
differences and comorbidity are important factors to consider in test development. The 
next section explores the impact of these factors on effective measurement of depression. 
Gender Differences. Gender influences depression diagnosis and measurement. 
Steer, Beck, and Brown (1989) found that response patterns from women often included 
affective and cognitive symptoms, while men combined affective and performance 
symptoms. This may be due to cultural differences between the sexes. Men may 
experience negative consequences from the display of emotion; therefore, they choose 
not to report symptoms. Women may not have the same social stigma attached to 
emotion; accordingly, they are more likely to report these types of experiences. More 
women than men seek treatment for depression indicating that depression might be more 
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prevalent in women than men (Alansari, 2006). Once diagnosed with depression, women 
report different experiences than men, including changes in appetite, interruptions or 
increase in sleep, fatigue, anxiety, and hypochondriasis (Piccinelli &Wilkinson, 2004). 
Because women most often report these symptoms, the inclusion of these symptoms on 
rating scales at the exclusion of items more specific to male depression may lead to 
increased diagnosis of women and decreased diagnosis of men. In their review of 74 
studies, Piccinelli and Wilkinson (2004) determined that few differences exist between 
male and female profiles. Although they did indicate that gender specific response 
patterns were evident on rating scales, they did not fully account for the apparent gender 
differences in prevalence. Kuehner's (2003) review of studies published between 1993 
and 2002 indicates that symptom severity affects the gender ratio, with the preponderance 
of gender disparity becoming more apparent as criterion symptoms increase. Kuehner 
(2003) also noted that research has not supported that a difference in depressive 
symptoms between men and women explains the difference in prevalence rate. Rather 
than differences in symptoms, Kuehner proposed that other factors such as sex hormones, 
personality, psychosocial factors, and stress might better account for the higher 
prevalence of depression in women. Therefore, it is difficult to determine if 
measurement leads to an increase in the diagnosis of depression in women or if women 
are more susceptible to depression and therefore more often diagnosed. 
Comorbidity. Since depression and anxiety so frequently overlap, their 
measurement poses psychometric challenges (Kocovski, Endler, Cox, & Swinson, 2004). 
The General Distress Factor Model, developed by Clark and Warson (1991), suggested 
that the two disorders have many shared symptoms and some unique symptoms. In order 
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to cope with this Clark and Warson proposed grouping these symptoms into three 
categories: General Distress, which incorporates the shared symptoms, Somatic Tension 
and Arousal that are unique to anxiety, and Anhedonia and Low Positive Affect, which 
are singularly depressive symptoms. General distress symptoms that are common to both 
depression and anxiety lead to difficulty measuring the constructs separately. Further, 
many anxiety and depression scales fail to distinguish between the two disorders 
(Kocovski et al., 2004). Since this issue of comorbidity is evident, it is important that new 
depression measures address the issues of the overlap between depressive and anxious 
symptoms. 
Depression Measures 
With depression so often co-occurring with other disorders, measurement tools 
for clinical symptoms often measure multiple components of psychological health. 
Broad-band measures assess a wide range of symptoms not just the area of interest. 
Narrow-band measures, however, evaluate specific areas of concern. Moreover, narrow-
band measures of depression rely heavily on the idea that the measurement of the 
construct of depression is independent from the measurement of other disorders (Stark & 
Kaslow, 1993). Broad-band measures are used to evaluate an individual when little is 
known for screening purposes, while narrow-band measures are most effective when an 
initial group of symptoms is known and diagnostic criteria need to be met. 
This study investigates the psychometric properties of the Clinical Assessment of 
Depression (CAD; Bracken & Howell, 2004). As a narrow-band measure, the CAD 
looks specifically at depression and its related symptoms. One method used to establish 
the validity of a newly developed measure is to compare it to an established measure. 
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Often it is helpful to look at a new measure's validity compared to existing narrow-band 
and broad-band measures. Hicks (2005) compared the CAD to the Beck Depression 
Inventory- 2nd edition (BDI-II), another narrow-band measure. However, this study 
focuses on comparing the CAD to a broad-band measure, the Brief Symptom Inventory -
4th edition (BSI; Derogatis, 1993). The BSI's brevity and scope of a wide range of 
psychological symptoms make it a desirable broad-band measure for comparison with the 
CAD. The following section discusses each measure used, its development, and 
psychometric properties. 
Clinical Assessment of Depression (CAD). Bracken and Howell (2004) developed 
the CAD to provide practitioners with an assessment instrument that is both reliable and 
valid across a wide age range (ages 8 to 79). The CAD is a 50-item self report 
questionnaire with responses recorded on a four-item Likert response scale (Strongly 
Disagree, Disagree, Strongly Agree, and Agree). The instrument yields T scores for a 
total depression assessment score and four subscale scores: Depressed Mood, 
Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue. Furthermore, 
the CAD contains three validity scales (Inconsistency, Negative Impression, and 
Infrequency) to aid in interpretation of findings. The Depressed Mood subscale 
investigates symptoms such as feelings of unhappiness, sadness, loneliness, poor self-
concept, and a pessimistic view. The Diminished Interest subscale examines anhedonia, 
a lack of excitement about the future or events previously enjoyed. The Anxiety/ Worry 
subscale includes items related to acute anxiety, worry, and fear. The Cognitive and 
Physical Fatigue scale includes symptoms such as sluggishness, fatigue, lack of 
restfulness, and difficulty taking actions that require energy. The CAD's four scales fit 
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well with DSM-IV criteria and make it one of the few measures to account for all 
symptoms of depression listed in the DSM-IV. The authors also recommend the CAD 
for treatment planning and progress monitoring. 
The CAD's normative population is proportionately representative of the 2001 
census data and stratified by gender, age, and ethnicity (Bracken & Howell, 2004). 
While the standardization sample generally matched the U.S. population, it evidences 
disproportionate representation of highly educated individuals. The sample evidences a 
smaller percentage of individuals with zero to 12 years of education and a larger 
percentage of individuals reporting 13 or more years of education than that of the U.S 
census. Total score coefficient alpha reliabilities for the standardization sample stratified 
by age range are high, ranging from .96 to .97. For the four scales, coefficient alpha 
reliabilities range from .78 to .96 with most exceeding the .90 criterion typically used for 
diagnostic decision-making (Bracken, 1987) The standard error of measurement for the 
T score ranges from 2 to 5, and the reliability coefficients for gender and ethnicity 
exceeded .82. Confirmatory factor analysis across the three age groupings supported the 
four-factor structure of the instrument. 
Independent research has supported the CAD manual data. Bowers (2004) 
examined the relationship between the Beck Depression Inventory- 2nd edition and the 
CAD using a sample of 122 young adults and found a significant positive correlation 
between the total scores (r = .77). Bowers (2004) also compared the CAD with Beck 
Depression Inventory- 2nd edition in college students and found the two significantly 
correlated. Tinsley (2004) found a significant positive correlation between the CAD and 
Reynolds Adolescent Depression Scale (RADS; r = .88). Classification consistency 
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between the CAD and the RADS was 83 percent for the total sample of 119 adolescents. 
Coefficient alpha for the CAD was .98, with item corrected correlations ranging from .81 
to .88 for the scales (Jones, Tinsley, & Bowers, 2005). Hicks (2005) examined the 
relationship between the CAD and the BDI-II and found strong, significant positive 
correlations between the BDI-II and each of the scales of the CAD. The reliability of the 
CAD and its scales is high with coefficient alphas ranging from .87 to .96. 
Research into the CAD's psychometric properties indicates that reliability is good 
across gender, age, and race for both clinical and nonclinical populations. Construct 
validity is supported through high correlations with existing narrow-band measures (BDI-
II and RADS) as well as confirmatory factor analysis that found strong intercorrelations 
between each subscale and total scale scores. One area that not investigated extensively 
or independently is the divergent validity of the scale using a broad-band measure of a 
variety of clinical symptoms. 
Brief Symptom Inventory - 4th Edition (BSI). Derogatis (1993) developed the BSI 
to improve diagnosis of a variety of psychological disorders. The BSI is a 53-item 
questionnaire that yields T scores for nine scales: Somatization, Obsessive-Compulsive, 
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid 
Ideation, and Psychoticism. The Somatization scale reflects distress arising from 
perceptions of bodily dysfunction. The Obsessive-Compulsive scale includes symptoms 
such as thoughts, impulses, and actions that are irresistible to the individual. The 
Interpersonal Sensitivity scale examines an individual's feelings of personal inadequacy 
and inferiority. The Depression scale examines symptoms such as dysphoric mood, lack 
of motivation, and a loss of interest in enjoyable activities. The Anxiety scale examines 
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signs of anxiety such as nervousness, feelings of terror, and panic attacks. The Hostility 
scale includes "thoughts, feelings or actions that are characteristic of the negative affect 
state of anger" (Derogatis, 1993 p. 8). The Phobic Anxiety scale investigates specific 
people, places, objects, or situations that cause irrational fear in respondents. The 
Paranoid Ideation scale investigates the extent of a respondent's fears involving 
projective thought, hostility, suspicion, grandiosity, and loss of autonomy. Finally, the 
Psychoticism scale investigates symptoms such interpersonal alienation and psychosis. 
These scales are congruent with a wide range of psychological disorders making the BSI 
a broad-band measure of clinical symptoms. The BSI also provides three broader scales 
to assess general psychological health: the Global Severity Index, the Positive Symptom 
Total, and the Positive Symptom Distress Index. The symptom scales combined with the 
broader total and index scores allow clinicians to investigate specific symptoms and the 
severity of the overall problem. 
The norms developed for BSI incorporate four distinct clinical normative samples 
(Derogatis, 1993): (a) 1,002 adult psychiatric outpatients, (b) 974 adult nonpatients, (c) 
423 adult psychiatric inpatients, and (d) 2,408 adolescent nonpatients. The first 
normative sample examined adult psychiatric outpatients and included 425 males and 577 
females. Two-thirds of the sample was White with socioeconomic status skewed toward 
the lower end. The second study used an adult nonpatient sample consisting of 494 males 
and 480 females. This study, however, provides limited information about participant 
demographics (i.e., race, marital status, or age). The third study involved adult 
psychiatric inpatients where females outnumbered males 2:1. The sample consisted of 
slightly more Whites than African-Americans. The last study used an adolescent 
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outpatient sample in which males outnumbered females 2:1. In this final study, six 
schools in two states contributed to the sample, and the racial profile was 58 percent 
White, 30 percent African-American, and 12 percent other. While norming of the BSI 
was extensive, it did not include non-clinical individuals and therefore may not be as 
accurate with individuals not experiencing psychological distress. 
In a separate study, data from a sample of 719 psychiatric outpatients provided 
internal consistency and reliability information. The alpha coefficients of the nine BSI 
scales ranged from .71 to .85 (Derogatis, 1993). Croog et al. (1986) verified scale 
reliabilities with a sample of 626 males. Derogatis (1993) established BSI's test-retest 
reliability and temporal stability by testing a sample of 60 nonpatients with alpha 
coefficients ranging from .68 (Somatization) to .91 (Phobic anxiety). 
Derogatis, Rickels and Rock (1976) established convergent validity for the BSI 
and MMPI. These results demonstrate positive correlations greater than or equal to .30 
among the scale scores for the two tests. The internal structure validity and construct 
validity of the BSI scales is evidenced in the factor analysis (Derogatis, 1993). Derogatis 
(1993) reproduced seven of the nine constructs. Factor analysis found no support for the 
Interpersonal Sensitivity scale. This lack of support may be due to a limited number of 
items on that scale. The Anxiety dimension emerged as two distinct and more specific 
factors, "Panic Anxiety" and "General Anxiety." Therefore, these items are now in 
separate scales. 
When independently reviewed, the internal consistency was found to be very 
acceptable, ranging from a low of .71 on the Psychoticism scale to a high of .83 on 
Obsessive-Compulsive scale. The test-retest reliabilities are also good, ranging from a 
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low of .68 on Somatization scale to a high of .91 on Phobic Anxiety scale (Cundick, 
2004). However, Cundick (2004) indicated that norms omitted populations representing 
large parts of the United States and therefore the creation of local norms may be 
appropriate. Cundick (2004) concluded that the BSI is technically sound and would be 
useful as an initial screening measure. Peterson's (2004) review indicated that the BSI's 
brevity is a considerable asset particularly with its "solid psychometric foundation, the 
multiple norms which help the clinician remain sensitive to fluctuations in base rates of 
psychopathology, and the test's ability to survey a fairly broad range of psychopathology" 
(p. 160). 
Purpose 
Depression represents a high incidence psychological disorder that increases the 
risk for health and interpersonal problems. Depression is a disorder that affects 19 
million adults annually with most individuals experiencing their first depressive episode 
between the ages of 15 and 19, corresponding with the age when most students are 
adjusting to college life (CASA, 2003). Fifty-three percent of college students 
experience some depression before graduating (CASA, 2003). Depression creates serious 
functional impairments and risks for college students including suicide, the second 
leading cause of death in this age group. 
Although depression affects both males and females, research findings indicate 
that females face a higher risk of becoming depressed (Kuehner, 2003; Mash & Wolfe, 
2005; Piccinelli & Wilkinson, 2004). Moreover, studies have shown that females report a 
wider range and more severe depressive symptoms than males (Kuehner, 2003; Piccinelli 
&Wilkinson, 2004). Currently, practitioners use the BSI as a broad-band measure to 
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screen for overall psychological distress, assess severity of symptoms and to aid 
diagnosis. Empirical support for the BSI is evident in the studies reviewed. The CAD 
represents a new, narrow-band instrument to diagnose and assess symptoms of 
depression. However, the CAD has not been tested and validated to the extent of BSI. A 
direct comparison of the CAD with BSI enables a test of the CAD's convergent and 
divergent validity. This investigation addresses the following hypotheses: 
Hypothesis 1: There will be significant, strong (r = .6 to 1.0) positive correlations 
between similar scales on the CAD and BSI: (a) the CAD Total 
and BSI Depression scale, (b) The CAD Anxiety/Worry scale and 
BSI Anxiety scale, and (c) the CAD Cognitive and Physical 
Fatigue scale and BSI Somatization scale. 
Hypothesis 2: There will be low to moderate correlations (r =.2 to .6) between 
scales on the CAD and BSI that are dissimilar: (a) the CAD Total 
and BSI Psychoticism scale and, (b) CAD Total and BSI Paranoid 
Ideation scale. 
Hypothesis 3: Classification consistency will exist between (a) the CAD Total 
and BSI Depression scale, (b) the CAD Anxiety/Worry and BSI 
Anxiety scale and, (c) the CAD Cognitive and Physical Fatigue 
scale and BSI Somatization scale. 
Hypothesis 4 : Females will evidence significantly higher scores on the CAD 
Total score than males. 
Method 
Participants 
The sample consists of 280 college students aged 18 to 52 years enrolled in 
undergraduate courses in psychology at a south central Kentucky university. Ninety 
percent of the sample, however, consists of individuals between the ages of 18 and 24. In 
terms of gender, more females than males participated in this study (74.3% female versus 
25.7% male). Of the students participating, 36 individuals reported a previously 
diagnosed psychological disorder (12.9% of the sample). Of these 36 individuals, 15 
reported ending treatment prior to participation in the current research study. Eighty-
three percent of the sample was White, ten percent Black, two percent Asian, and five 
percent other. The majority of the sample was freshman students (41%), sophomores and 
juniors each represented 20%, and seniors represented 18%. 
Measures 
Clinical Assessment of Depression. The CAD is a 50-item questionnaire that 
measures a variety of depressive symptoms with responses recorded on a four-item Likert 
response scale (Strongly Disagree, Disagree, Strongly Agree, and Agree). The 
instrument yields T scores (mean of 50, standard deviation of 10) for a total score and 
four subscale scores: Depressed Mood, Anxiety/Worry, Diminished Interest, and 
Cognitive and Physical Fatigue. One standard deviation above the mean is considered 
Mild Clinical Risk, two standard deviations above the mean is consider Moderate 
Clinical Risk and three of more standard deviations above the mean is considered 
Significant Clinical Risk. The CAD also measures three validity scales (Inconsistency, 
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Negative Impression, and Infrequency), and provides information about specific 
symptoms of depression. 
Total score results for the standardization sample stratified by age yielded 
coefficient alpha reliabilities from .96 to .97. Moreover, tests of the four scales resulted 
in coefficient alpha reliabilities from .78 to .96. Most of the alphas exceeded .90, which, 
according to Bracken (1987), represents the appropriate reliability cutoff for scales used 
in diagnostic decision-making. The standard error of measurement for .the T-score 
ranged from two to five, and the reliability coefficients for gender and ethnicity exceeded 
.82. 
The CAD results obtained in this study are consistent with prior independent 
research. Bowers (2004) compared the Beck Depression Inventory- 2nd edition (BDI-II) 
with the CAD and found a significant positive correlation between the total scores (r 
=.77). Moreover, Tinsley (2004) found a significant positive correlation between the 
CAD and the Reynolds Adolescent Depression Scale (RADS, r =.88). In both of these 
prior studies, coefficient alphas for the CAD scales consistently exceeded .95, with item 
corrected correlations ranging from .81 to .88 for the scales (Jones, Tinsley & Bowers, 
2004). Hicks (2005) also found significant positive correlations between BDI-II and the 
CAD scales. 
Brief Symptom Inventory- 4th Edition. The BSI is a 5 3-item questionnaire that 
measures a variety of psychological distress symptoms and yields T scores (mean of 50, 
standard deviation of 10) for nine subscale scores: Somatization, Obsessive-Compulsive, 
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, and Paranoid 
Ideation. These symptom dimensions are congruent with a wide range of psychological 
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disorders making the BSI a broadband measure. The BSI also provides T scores for three 
broader scales to assess general psychological health: Global Severity Index, Positive 
Symptom Total, and Positive Symptom Distress Index. The specific scales combined 
with the broader scores allow clinicians to investigate specific symptoms and the severity 
of the overall problem. An individual can demonstrate clinically significant responses in 
two ways, a Global Severity score of 63 or higher or two scale scores of 63 or higher. 
Croog et al. (1986) used a sample of 626 males to establish BSI scale reliabilities 
(coefficient alphas ranging from .78 to .83). Subsequently, Derogatis (1993) replicated 
the results from Croog et al. (1986) across the nine BSI dimensions finding alpha 
coefficients ranging from .71 to .85. A sample of 60 nonpatents provided data for the 
test-retest reliability and evidenced reliabilities between .68 for Somatization and .91 for 
Phobic anxiety (Derogatis, 1993). Derogatis, Rickels & Rock (1976) established 
convergent validity for the BSI and MMPI. These results demonstrate positive 
correlations among the scale scores for the two tests. 
Demographic Questionnaire. A demographic questionnaire was developed to 
quantify and describe the sample (see Appendix A). The form asks participants to 
provide gender, race, age, and history of depression/psychological treatment. 
Procedure 
This study involved undergraduate psychology students recruited through the 
Student Study Board at a south central Kentucky university. The Study Board is an 
electronic resource for students to sign up and schedule time to participate in research 
studies. Additional participants joined this study through classroom sign ups in a variety 
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of undergraduate psychology courses not participating in the Student Study Board. At a 
participant's scheduled time, he (or she) completed a consent form (see Appendix B). 
The data packet included the Beck Anxiety Inventory (BAI) and the Beck 
Depression Inventory-2nd edition (BDI-II) in addition to the demographic form, the BSI, 
and the CAD because the data collection was concurrent with other research projects. 
Upon receiving a participant's completed consent form, respondents provided 
demographic information and received a packet of forms (CAD, BDI-II, BAI, and BSI). 
The order of forms in packets was determined for each participant using a counter-
balanced order to control for order effects. Participants returned completed materials to 
the administrator and received a debriefing statement along with credit for participation 
(see Appendix C). 
A coding system ensured participant confidentiality by keeping names separated 
from the data packets. This system allowed for participant identification without 
including names on the test forms. Participant identification allowed researchers to 
identify and contact participants in the event of clinically significant scores on the 
measures. The primary investigator met with participants exhibiting clinically significant 
responses. During the meeting, the primary investigator presented participants with 
information about depression and resources. The University's Human Subjects Review 
Board approved all procedures (see Appendix D). 
Results 
This section presents the descriptive statistics for the sample and the measures as 
well as the analyses and data addressing the four sets of hypotheses. 
Descriptive Statistics. Table 1 presents the descriptive statistics for sample's 
performance on the measures. Mean T scores for both males and females fell within the 
average range (50-59) for all scales and total scores of the CAD and BSI. 
Hypotheses I and 2. Table 2 presents the Pearson r correlations computed to 
address the first two hypotheses that predicted the strength of the relationship between 
the CAD and BSI scales. Control for Type I error was obtained using the Bonferroni 
approach due to the large number of correlations computed. Using this correction, 
significance levels below p = .003 are significant. Hypothesis 1 predicted statistically 
significant, strong positive correlations (.60 to 1.0) between the following specific scales: 
(a) CAD Total score and BSI Depression scale, (b) CAD Anxiety/Worry scale and BSI 
Anxiety scale, and (c) CAD Cognitive and Physical Fatigue scale and BSI Somatization 
scale. As shown in Table 2, all correlations were significant at the = .001 level. 
Hypothesis 1, i.e., statistically significant and strong (.6 to 1.0) correlations between 
similar scales was only partially supported. The only strong correlation predicted was 
between the BSI Global Severity Index and the CAD Total (r = .62, p < .001). The other 
scales evidence significant, moderate level correlations: (a) the CAD total score and BSI 
Depression scale (r = .58, p < .001); (b) CAD Anxiety/Worry scale and BSI Anxiety 
Scale (r = .57,/? < .001) and (c) CAD Cognitive and Physical Fatigue scale and BSI 




Descriptive Statistics for the Brief Symptom Inventory (BSI) and the Clinical Assessment of 
Depression (CAD). 
Mean Range Standard Deviation 
CAD Anxiety and Worry Scale 
Male 50.18 29-79 12.24 
Female 52.23 29-79 11.67 
Total 51.70 29-79 11.83 
CAD Cognitive and Physical Fatigue Scale 
Male 49.68 30-76 11.32 
Female 52.23 30-82 11.12 
Total 51.84 30-82 11.22 
CAD Depressed Mood Scale 
Male 52.56 38-79 10.81 
Female 50.50 38-82 9.98 
Total 51.03 38-82 10.22 
CAD Diminished Interest Scale 
Male 53.08 38-82 11.17 
Female 51.57 28-89 10.84 
Total 51.96 28-89 10.93 
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Table 1 (continued) 
Mean Range Standard Deviation 
CAD Total Score 
Male 51.79 33-82 11.80 
Female 51.98 33-120 11.83 
Total 51.93 22-120 11.80 
BSI Somatization Scale 
Male 53.29 41-78 9.87 
Female 53.88 41-80 9.75 
Total 53.73 41-80 9.76 
BSI Obsessive Compulsive Scale 
Male 60.32 38-80 12.14 
Female 58.52 37-80 10.66 
Total 58.98 37-80 11.06 
BSI Interpersonal Sensitivity Scale 
Male 57.25 41-80 12.33 
Female 57.00 41-80 10.59 
Total 57.06 41-80 11.04 
BSI Depression Scale 
Male 56.99 28-80 12.16 
Female 53.40 38-75 9.59 
Total 54.32 28-80 10.41 
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Table 1 (continued) 
Mean Range Standard Deviation 
BSI Anxiety Scale 
Male 53.58 38-80 12.36 
Female 52.01 38-79 10.27 
Total 52.42 38-80 10.94 
BSI Hostility Scale 
Male 56.34 39-80 11.02 
Female 55.24 39-80 10.63 
Total 55.52 39-80 10.72 
BSI Phobic Anxiety Scale 
Male 53.43 40-74 9.73 
Female 52.43 41-80 8.56 
Total 52.69 40-80 8.87 
BSI Paranoid Scale 
Male 55.47 42-80 11.51 
Female 56.19 42-80 9.75 
Total 56.00 42-80 10.22 
BSI Psychoticism Scale 
Male 58.51 46-80 11.62 
Female 57.92 42-80 10.24 
Total 58.07 42-80 10.59 
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Table 1 (continued) 
Mean Range Standard Deviation 
BSI Global Severity Index 
Male 58.24 33-80 12.49 
Female 56.61 33-80 9.99 
Total 57.03 33-80 10.69 
Note. Total N= 280; Male N = 72; Female N = 208. Values expressed as T scores. 
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Table 1 
Correlations Between Brief Symptom Inventory (BSI) and Clinical Assessment of Depression (CAD) 
Scales. 
Scale 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. BSI- GSI - .71 .80 .75 .74 .76 .73 .62 .74 .76 .62 .55 .66 .53 .65 
2. BSI- SOM - .55 .47 .48 .61 .50 .48 .50 .49 .46 .41 .48 .40 .50 
3. BSI- O-C - .52 .55 .61 .62 .47 .49 .54 .49 .39 .58 .41 .59 
4. BSI- IS - .57 .55 .55 .48 .62 .60 .51 .47 .55 .42 .49 
5. BSI- DEP - .51 .58 .50 .56 .65 .58 .58 .54 .59 .59 
6. BSI- ANX - .52 .56 .54 .55 .48 .41 .57 .42 .52 
7. BSI- HOS - .39 .57 .55 .49 .41 .52 .44 .58 
8. BSI- PHOB - .48 .52 .45 .42 .45 .42 .45 
9. BSI- PAR .61 .49 .44 .48 .39 .45 
10. BSI- PSY - .57 .54 .54 .48 .52 
11. CAD Total - .91 .84 .85 .85 
12. CAD- DM - .72 .83 .73 
13. CAD- AW .67 .80 
14. CAD- DI .77 
15. CAD-CPF 
Note. N= 280. GSI = Global Severity Index; SOM = Somatization Scale; O-C = Obsessive 
Compulsive Scale' I-S = Interpersonal Sensitivity Scale; Dep = Depression Scale, Anx= Anxiety 
Scale; Hos= Hostility Scale; Phob= Phobic Anxiety Scale; Par = Paranoid Ideation Scale; Psy = 
Psychoticism Scale' Total = Total Score DM = Depressed Mood Scale; AAV = Anxiety/Worry Scale; 
DI = Diminished Interest Scale; CPF = Cognitive/ Physical Fatigue Scale. 
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Hypothesis 2 examines whether significant, positive, and moderate level 
correlations exist between the following scales: (a) CAD Total score and BSI 
Psychoticism scale and, (b) CAD Total score and BSI Paranoid Ideation scale. The 
results support this hypothesis with all correlations being significant and at the moderate 
level: (a) CAD Total Score and BSI Psychoticism (r = .57,p < .001) and (b) CAD Total 
score and BSI Paranoid Ideation (r = .49, p < .001). 
Other interesting correlational findings include moderate correlations between 
CAD Anxiety/Scale with the BSI Obsessive Compulsive, Interpersonal Sensitivity, 
Hostility, and Psychoticism scales. The CAD Depressed Mood and Diminished Interest 
Scales were also moderately correlated with the BSI Psychoticism scale. The CAD 
Cognitive and Physical Fatigue scale was also moderately correlated with both the 
Obsessive Compulsive and Hostility BSI scales. 
Hypothesis 3. Hypothesis 3 examined the classification consistency using the BSI as the 
criterion measure (Table 3). Investigation of classification consistency employed the use 
of a 2 X 2 contingency table for all CAD scales with the scales of the BSI identified as 
closely related to the CAD: Somatization, Anxiety, Depression, and Global Severity 
Scales at several classification levels or clinical significance levels for each measure. 
The BSI manual (Derogatis, 1993) supports the interpretation of clinically 
significant scores at the following levels: (a) Global Severity Index greater than or equal 
to a T score of 63 or (b) two or more subscale scores greater than or equal to a T score of 
63. The CAD manual (Bracken & Howell, 2004) advocates for the use of three levels of 
clinical significance: (a) one standard deviation above the mean (T > 60), (b) two 
standard deviations above the mean (T > 70), and (c) three standard deviations above the 
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Table 1 
Sensitivity, Specificity, and Classification Consistency between the Brief Symptom 
Inventory (BSI) and the Clinical Assessment of Depression (CAD) 
Sensitivity Specificity Consistency 
CAD Criterion GSI 2 scales GSI 2 scales GSI 2 scales 
T > 63 T > 63 T>63 T>63 T>63 T>63 
CAD Cognitive and Physical Fatigue Scale/ BSI Somatization Scale 
T > 60 43% 48% 91% 78% 79% 65% 
T > 70 44% 65% 84% 69% 82% 67% 
T > 80 33% 33% 83% 67% 82% 66% 
CAD Cognitive and Physical Fatigue Scale/ BSI Depression Scale 
T > 60 55% 60% 90% 72% 81% 67% 
T > 70 61% 69% 81% 61% 80% 62% 
T > 80 100% 100% 79% 59% 80% 60% 
CAD Cognitive and Physical Fatigue Scale/ BSI Anxiety Scale 
T > 60 41% 44% 87% 67% 76% 57% 
T > 70 39% 44% 82% 62% 79% 60% 
T > 80 33% 33% 81% 62% 80% 61% 
CAD Cognitive and Physical Fatigue Scale/ BSI Global Severity Index 
T > 60 71% 67% 79% 59% 77% 60% 
T > 70 78% 78% 70% 45% 70% 60% 
T > 80 100% 88% 68% 38% 68% 43% 
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Table 1 (continued) 
Sensitivity Specificity Consistency 
GSI 2 scales GSI 2 scales GSI 2 scales 
CAD Criterion T>63 T>63 T>63 T>63 T>63 T>63 
CAD Anxiety/Worry Scale/ BSI Somatization Scale 
T > 60 38% 41% 90% 74% 76% 57% 
T > 70 54% 54% 86% 71% 83% 68% 
T > 80 - - -
CAD Anxiety/Worry Scale/ BSI Depression Scale 
T > 60 53% 57% 90% 71% 80% 64% 
T > 70 75% 75% 84% 64% 83% 66% 
T > 80 - - -
CAD Anxiety/Worry Scale/ BSI Anxiety Scale 
T > 60 50% 54% 91% 76% 80% 65% 
T > 70 67% 67% 85% 68% 83% 67% 
T > 80 - - -
CAD Anxiety/Worry Scale/ BSI Global Severity Index 
T > 60 72% 77% 81% 46% 78% 61% 
T > 70 96% 96% 73% 41% 75% 50% 
T > 80 
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Table 1 (continued) 
Sensitivity Specificity Consistency 
GSI 2 scales GSI 2 scales GSI 2 scales 
CAD Criterion T>63 T>63 T>63 T>63 T>63 T>63 
CAD Depressed Mood/ BSI Somatization Scale 
T > 60 38% 46% 88% 74% 77% 64% 
T > 70 54% 54% 84% 69% 83% 67% 
T > 80 67% 67% 83% 67% 83% 67% 
CAD Depressed Mood Scale/ BSI Depression Scale 
T > 60 59% 26% 89% 75% 83% 74% 
T > 70 93% 93% 82% 63% 83% 65% 
T > 80 100% 100% 79% 59% 80% 60% 
CAD Depressed Mood Scale/ BSI Anxiety Scale 
T > 60 40% 50% 87% 68% 76% 62% 
T > 70 54% 54% 82% 63% 81% 62% 
T > 80 67% 50% 81% 62% 81% 62% 
CAD Depressed Mood Scale/ BSI Global Severity Index 
T > 60 63% 67% 76% 59% 73% 60% 
T > 70 92% 80% 70% 43% 71% 56% 
T > 80 100%, 92% 68% 38% 68% 43% 
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Table 1 (continued) 
Sensitivity Specificity Consistency 
GSI 2 scales GSI 2 scales GSI 2 scales 
CAD Criterion T>63 T>63 T>63 T>63 T>63 T>63 
CAD Diminished Interest Scale/ BSI Somatization Scale 
T > 60 38% 43% 89% 74% 76% 85% 
T > 70 58% 65% 85% 71% 84% 70% 
T > 80 67% 67% 83% 67% 83% 67% 
CAD Diminished Interest Scale/ BSI Depression Scale 
T > 60 51% 59% 89% 71% 79% 65% 
T > 70 58% 65% 81% 60% 80% 61% 
T > 80 100% 100% 79% 59% 80% 60% 
CAD Diminished Interest Scale/ BSI Anxiety Scale 
T > 60 36% 41% 86% 64% 73% 54% 
T > 70 53% 59% 83% 65% 81% 64% 
T > 80 67% 67% 81% 62% 81% 62% 
CAD Diminished Interest Scale/ BSI Global Severity Index 
T > 60 61% 70% 76% 38% 73% 52% 
T > 70 79% 88% 70% 38% 71% 44% 
T > 80 100% 100% 68% 36% 68% 37% 
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Table 1 (continued) 
Sensitivity Specificity Consistency 
GSI 2 scales GSI 2 scales GSI 2 scales 
CAD Criterion T > 63 T > 63 T >63 T>63 T>63 T>63 
CAD Total Score/ BSI Somatization Scale 
T> 60 37% 42% 89% 73% 76% 60% 
T> 70 58% 61% 85% 71% 84% 70% 
T > 80 25% 25% 83% 66% 82% 65% 
CAD Total Score/ BSI Depression Scale 
T > 60 60% 67% 91% 75% 83% 72% 
T > 70 74% 78% 82% 63% 82% 65% 
T > 80 75% 75% 79% 58% 79% 59% 
CAD Total Score/ BSI Anxiety Scale 
T > 60 40% 45% 87% 67% 76% 57% 
T > 70 63% 67% 84% 66% 82% 66% 
T > 80 25% 25% 80% 61% 80% 60% 
CAD Total Score/ BSI Global Severity Index 
T > 60 70% 78% 78% 44% 76% 59% 
T> 70 84% 89% 70% 38% 71% 45% 
T> 80 75% 75% 67% 35% 68% 36% 
Note. N = 280. GSI = Global Severity Index of the BSI. 2 scales = any two BSI scales. 
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mean (T > 80). Computation of classification consistency involved computing the 
percentage of accurate referrals (sensitivity) and accurate nonreferrals (specificity) and 
expressing the value as a percentage. Lidz (2003) recommends as acceptable 
classification consistency percentages of 80 or above. None of the scale comparisons 
were found to have acceptable classification consistency using the BSI two or more 
scales greater than or equal to a T score of 63 criterion with each of the three CAD 
criteria. 
When using the BSI Global Severity Index at or above a T score of 63 criterion, 
all CAD scales evidenced acceptable classification consistency at the two and three 
standard deviation above the mean criteria on the CAD with all investigated BSI scales 
except the Global Severity Index. One exception is noted. No one qualified for the CAD 
Anxiety/ Worry scale at the three standard deviation level, therefore classification 
consistency could not be calculated. When using the CAD one standard deviation above 
the mean criteria, adequate classification consistency (> 80%) emerged only sporadically 
appearing between the CAD total score and CAD Anxiety/ Worry scale with the BSI 
Depression scale. 
Acceptable classification consistency evidences most frequently when using the 
BSI Global Severity Index at or above a T score of 63 and the CAD two standard 
deviation classification criterion (15 out of 20 comparisons). The combination of the two 
criterion resulted in acceptable classification consistency for all CAD scales with the BSI 
Somatization, Depression and Anxiety Scales. 
When looking at classification consistency, it is also important to address 
sensitivity and specificity. Sensitivity refers to the ability of a measure to classify 
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abnormal results as abnormal while specificity relates to a measure's ability to identify 
normal results as normal. As sensitivity goes up specificity goes down and vice versa. 
Therefore, it is essential to create a balance of the two in order to avoid over or under 
identification. Sensitivity emerged sporadically and did not appear in a systematic 
fashion, but when it did emerge it was at the two or three standard deviation on the CAD 
criterion. When sensitivity emerges, poor classification consistency emerges. When 
classification consistency occurs, poor sensitivity was apparent except for comparisons 
between (a) CAD Diminished Interest scale and BSI depression scale, (b) CAD 
Depressed Mood scale and BSI Depression Scale and, (c) CAD Cognitive and Physical 
Fatigue scale with the BSI Depression scale. 
Acceptable specificity is 90% or above (Lidz, 2003). No acceptable specificity 
was found when using the two BSI scales T score above 63 criteria. When using the BSI 
Global Severity Scale T score of 63 or above criteria specificity was not consistently 
acceptable. Good specificity was noted between the following: (a) the CAD Total Score 
at the one standard deviation and the BSI Depression Scale (b) the CAD Anxiety/Worry 
Scale at one standard deviation level and the BSI Somatization scale, the BSI Depression 
Scale and the BSI Anxiety Scale and (c) the CAD Cognitive and Physical Fatigue scale at 
the one standard deviation level and the BSI Somatization Scale. 
Hypothesis 4. Hypothesis 4 examines if females will evidence significantly 
higher scores on the CAD than males was addressed using two-tailed independent 
samples /-tests to determine the difference in total scores relative to gender. There were 
no significant mean differences (t (278) = -A\A,p< .909) between male and female 
scores on the CAD or the BSI. Thus, the data does not support Hypothesis 4. 
Discussion 
The current study investigated the convergent and divergent validity of the CAD 
with the BSI. Strong correlations (r = .6 to 1.0) were expected between (a) the CAD total 
score and BSI Depression scale, (b) the CAD Anxiety/Worry scale and BSI Anxiety 
scale, and (c) the CAD Cognitive and Physical Fatigue scale and BSI Somatization scale. 
Low to moderate correlations were expected between (r 2 to .6) between scales on the 
CAD and BSI that are dissimilar: (a) the CAD Total and BSI Psychoticism scale and, (b) 
CAD Total and BSI Paranoid Ideation scale. Classification consistency between the two 
measures was also investigated along with gender differences in the mean scores. 
Hypothesis 1 examined the convergent validity of the CAD and the BSI and 
revealed some interesting findings. Only one of the correlations of concern evidenced a 
strong correlation. This was between the CAD Total score and the BSI Global Severity 
Index {r = .62). The other scales comparisons evidenced only moderate level 
correlations: CAD Total score and the BSI Depression scale (r = .58); CAD 
Anxiety/Worry scale and the BSI Anxiety scale (r = .57); CAD Cognitive and Physical 
Fatigue scale and BSI Somatization scale (r = .50). While these results support the fact 
that the two measures are related, they did not show as strong a relationship as predicted. 
Other strong correlations are evident in addition. The BSI Global Severity Index 
evidenced strong correlations with the CAD Anxiety Worry Scale (r = .66), and the CAD 
Cognitive and Physical Fatigue Scale (r = .65). These findings do support Hypothesis 1 
predicting convergent validity between the two measures and more specifically between 
the CAD and the BSI's scales. However, the strength of the correlation is not as high as 
expected. One possible explanation is that since strong correlations were identified only 
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by using the BSI Global Severity Index, the scales consist of too few items to support a 
strong relationship with the CAD. It is also possible that the BSI Global Severity Index 
measures general affectivity that is associated with the overlap between anxiety and 
depression more effectively than the scales. While the BSI depression scale did not 
correlate strongly with CAD, BSI scales that are most similar to the CAD scales have 
moderate correlations (> .5) with all CAD scales. For example, the Depression scale is 
moderately correlated with all CAD scales, the Anxiety scale is moderately correlated (r 
= .4-.6) with CAD Anxiety/Worry Scale and Cognitive and Physical Fatigue scale, and 
the Somatization scale is moderately correlated with the CAD Cognitive and Physical 
Fatigue scale. 
Hypothesis 2 examined divergent validity between the measures. A moderate 
correlation was found between the CAD Total score and the BSI Psychoticism scale (r = 
.57). A moderate correlation was also found between the CAD total score and the BSI 
Paranoid Ideation scale (r = . 49). These findings support Hypothesis 2, predicting 
moderate level correlations as evidence for divergent validity between the two measures. 
Upon further examination of the correlations a general pattern is evident for high-
level moderate correlations (>.50) between all CAD scales and the BSI GSI and 
Depression scales. Correlations falling on the lower end of the moderate level (<.49) 
were noted between more dissimilar BSI scales and the CAD scales. There were some 
exceptions noted to this pattern on the BSI scales - such as the Somatization scale, 
Obsessive-Compulsive scale, Interpersonal Sensitivity scale, and Psychoticism-
specifically with the CAD Anxiety/Worry scale. These scales include symptoms with 
substantial anxiety components, which may account for the stronger correlations. 
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Previous research indicates that the CAD's convergent validity with the Beck 
Depression Inventory (BDI-II) and Reynolds Adolescent Depression Scale ([RADS]; 
Bowers, 2004; Tinsley, 2004) yielded correlations between the two measures in the 
strong range ((r = .6 to 1.0). The correlations in the current study are not as strong as 
predicted; however, the BSI covers a wider range of symptoms of psychological distress 
rather than the single construct of depression, assessed by the BDI-II, or anxiety, assessed 
by the RADS. The hypothesized predictions are based on correlations of CAD with o.ther 
narrow-band measures (RADS, BDI), not a broad-band measure like BSI. Interestingly, 
the BSI Psychoticism scale was moderately correlated to the CAD total score. This 
relationship may be due to the items within the Psychoticism scale such as, "feeling 
lonely even when you are with people," "never feeling close to another person," and 
"The idea that you are should be punished for your sins." These items may be associated 
with withdrawal and feelings of isolation that are also symptoms noted with depression. 
They are also measured on the CAD with such items as, "No one seems to care about 
me," and "I feel like I'm being punished." 
Hypothesis 3 examined the classification efficacy using the BSI as the criterion 
measure. Acceptable classification consistency (80%) was found most frequently when 
using the BSI Global Severity Index at or above a T score of 63 and the CAD two 
standard deviation classification criterion. The combination of the two criterion resulted 
in acceptable classification consistency for all CAD scales with the BSI Somatization, 
Depression, and Anxiety Scales. The BSI Global Severity Index did not demonstrate 
acceptable classification consistency with any of the CAD scales. This is possibly due to 
the nature of the Global Severity Index, which incorporates a variety of psychological 
symptoms while the CAD focuses specifically on depression. 
Further analysis looked at the sensitivity and specificity between the two 
measures. Sensitivity emerged only sporadically, but when found it occurred at the two 
and three standard deviations level criterion of the CAD. When sensitivity emerged, 
classification consistency did not occur except in comparisons between: (a) CAD 
Diminished Interest scale and BSI depression scale, (b) CAD Depressed Mood scale and 
BSI Depression Scale, and (c) CAD Cognitive and Physical Fatigue scale with the BSI 
Depression scale. These findings support the concurrent validity between the two 
measures. As was anticipated, the BSI Depression scale provided adequate consistency 
across all of the CAD scales and the total score. 
Hypothesis 4 examined gender differences for the mean score of the CAD. There 
were no significant mean differences (t [278] = - .114,p< .909) between male and female 
scores on the CAD or the BSI. Previous research indicates that women experience a 
greater number of depressive symptoms and often with more intensity (Kuehner, 2003). 
However, Hicks (2005) indicated similar findings with no significant mean differences 
between genders on the CAD scales. The current data further support that the CAD 
identifies depressed males and females equally well. Norman (2004) discusses the 
possibility that gender differences in the prevalence of depression may be related to 
women's roles in society as well as their status and the learned helplessness associated 
with a subservient role. Norman also notes two explanations for the higher prevalence of 
depression in women: (a) the physiology of reproduction such as hormonal variation and 
(b) women's roles and status. Women's role in society, such as subservience, leads to a 
sense of helplessness and creates an increased susceptibility to stress and depression 
(Norman, 2004). Norman (2004) further notes that the consistency of the gender ratio in 
prevalence rates lends strength to the physiological explanation. Since the sample within 
the current study consisted of a more homogenous, high achieving sample, it is possible 
that gender differences did not appear because there was not a significant difference 
between societal role and status between male and female participants. Further, 
Bromberger et al. (2004) discusses the implications of socioeconomic status related to 
depression. Since the current sample consisted of a narrow range of socioeconomic status 
it is possible that differences between participants were not as apparent as they would be 
within a more diverse sample. 
Limitations 
It is important to understand limitations of the study to be able to interpret the 
findings. Participants came from a limited geographic area that may be associated with 
specific cultural implications. Investigators recruited students from undergraduate 
psychology classes who self selected to participate or were encouraged to participate via 
extra credit in a class. This self-selection bias may be a threat to internal validity. All 
participants were college students and therefore were highly educated. As college 
students, most participants are likely to come from backgrounds of moderate to high 
socioeconomic status. Previous research (Bromberger, et al., 2004) has indicated that 
lower socioeconomic status can be an indicator of greater rates of depression. The 
compressed distribution of the socioeconomic status of participants in the current 
research study may not generalize to a larger population. In addition, the majority of 
participants were White with few Black, Asian, or other minority participants. Since 
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ethnicity can affect the appearance of depression (Simpson et al., 2006) the limited nature 
of the sample may represent a threat to external validity. 
Further Research 
In regards to future research, the psychometric properties of the CAD need to be 
further investigated. Additional research into the factor structure of the CAD will further 
support its structure and efficacy. Studies addressing additional age groups, ethnicities, 
and clinical groups may help to clarify the usefulness of the CAD. The BSI's 
psychometric properties should also be further investigated. The usefulness of the 
classification criterion of two or more scales above 63 should be investigated in order to 
address possible over identification. Furthermore, additional studies should include 
expanded geographic areas in order to enhance the generalizability of the findings. 
Additional research into the CAD usefulness across the lifespan is also important. Use of 
the CAD with older adults has not yet been investigated. 
Practical Implications 
The major implication of the current study is that psychometric evidence has been 
established and provided for the CAD's use as a measure for assessing depression. The 
classification efficacy when using the BSI Depression scale was high. The BSI is 
primarily designed as a screening instrument while the CAD is more useful for diagnostic 
purposes. Therefore, if the BSI is administered and a client is found to have met the BSI 
Global Severity Index criterion and has a significant Depression scale score, the CAD 
may be administered in order to further investigate a diagnosis. The BSI Global Severity 
Index criterion was found to be more useful than using the BSI Depression scale 
independently due to a lack of specificity. An elevated Global Severity Index indicates 
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that an individual is experiencing overall psychological distress and the scales assist with 
determining the area of that stress. When the BSI indicates depression as an area of 
concern, the CAD can assist practitioners in determining the best course of action. 
Furthermore, the CAD seems to be equally effective with both men and women. 
Depression creates serious functional impairments and risks for college students 
including suicide, the second leading cause of death in this age group (CASA, 2003). 
With such severe and far-reaching implications of depression, it is essential that 
psychological measures are accurate and effective in identifying individuals suffering 
from depression. Measures that can adequately identify and diagnose depressive 
symptoms will increase the likelihood of accurate treatment. 
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Have you ever been diagnosed with a psychological disorder? Circle One Yes No 
If yes, please respond to the following: 
Who made the diagnosis? Family Doctor Counselor 
Social Worker Psychologist 
Psychiatrist 
What was your diagnosis? 
Are you currently under treatment? Check all that apply: Therapy/Counseling 
Medication 









Social and Emotional Weil-Being Study 
Project Title: Emotional Weil-Being Study 
Investigators: Elizabeth L. Jones, Ph.D., Shelley Hicks, and Carlie West 
Department of Psychology, 745-4414 
You are being asked to participate in a project conducted through Western Kentucky University investigating the 
usefulness of 4 measures of social and emotional well-being used with young adults. Please read the following 
information carefully. It describes the purpose of the study, the procedure to be used, risks, and benefits of your 
participation and what will happen to the information that is collected from you. If you agree to participate in 
this project, Western Kentucky University requires that you give your signed agreement to participate in this 
project. 
The investigator will explain to you in detail the purpose of the project, the procedures to be used, and the 
potential benefits and possible risks of participation. You may ask him/her any questions you have to help you 
understand the project. A basic explanation of the project is written below. Please read this explanation and 
discuss with the researcher any questions you may have. 
If you then decide to participate in the project, please sign on the last page of this form in the presence of the 
person who explained the project to you. You should be given a copy of this form to keep. 
1. Nature and Purpose of the Project: The purpose of this study is to evaluate a new questionnaire 
designed to assess social and emotional well-being in young adults. 
2. Explanation of Procedures: Upon your consent, you will be asked to complete a packet of 4 
questionnaires concerning your thoughts, feelings, and emotions as they related to your day-to-day functioning. 
It will take approximately 30 minutes to complete these 4 questionnaires. 
3. Discomfort and Risks: There are no physical risks involved in filling out the questionnaires. 
However, answering the items may cause you to feel some emotional discomfort, due to the nature of the 
questions asked. 
4. Benefits: You may be able to receive extra credit for you psychology courses, if you instructor offers 
such credit (be sure to check with your instructor). 
5. Confidentiality: All information collected will be kept strictly confidential and will be accessible only 
to the project staff. In addition, all names will be kept separate from the questionnaires. However, if your 
responses to these questionnaires indicate that you may be of harm to yourself or to other people, the researchers 
will immediately inform you. 
6. Refusal/Withdrawal: Refusal to participate in this study will have no effect on any future services you 
may be entitled to from the University. Anyone who agrees to participate in this study is free to withdraw from 
the study at any time with no penalty. 
7. Questions: Can be directed to the researchers collecting data or to Dr. Elizabeth Jones. Dr. Jones can 
be reached in her office (260 TPH) during her office hours (see schedule on her door) or at (270)745-4414. 
You understand also that it is not possible to identify all potential risks in an experimental procedure, and you 
believe that reasonable safeguards have been taken to minimize both the known and potential but unknown risks. 
Signature of Participant Date 
Witness Date 
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY 
THE WESTERN KENTUCKY UNIVERSITY HUMAN SUBJECTS REVIEW BOARD 






Thank you for participating in this research study. This study was designed to examine 
the usefulness of a new measure of depression, the Clinical Assessment of Depression. 
For example, does the Clinical Assessment of Depression measure depression as will as 
other measures in the field such as the Beck Depression Inventory and the Brief 
Symptom Index? If you would like a final copy of the research project, please contact 
Dr. Elizabeth Jones at (270)745-4414, or at the Department of Psychology, Western 
Kentucky University, 1 Big Red Way, Bowling Green, KY 42101. The final copies will 
not be available until after December 1, 2005. 
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Appendix D 
Letter of Human Subjects Review Board Approval 
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W E S T E R N K E N T U C K Y U N I V E R S I T Y 
Human Subjects Review Board 
Off icc of Sponsored Programs 
106 Foundat ion Bui lding 
270-745-4652: Fax 270-745-4211 
E-mail: Sean.Rubinoff l )wku.edu 
In future cor respondence please le fer to HS05-087 . Feb rua i} 15, 2005 
Dr. El izabeth Jones 
260 T P H 
Depar tmen t of Psycho logy 
W K U 
Dear Dr. Jones: 
Your revision to your research project . "Validity of the Clinical Assessment of Depress ion , " was reviewed 
b> the H S R B and t( has been dete imined that risks to subjects are: (1) min imized and reasonable ; and that 
(2) i c sea ich procedures are consistent with a sound research design and do not expose the subjec ts to 
unnecessary risk. Rev iewers determined that (1) benefi ts to subjec ts are considered a long with the 
impor tance of the topic and that ou tcomes are reasonable . (2 ) selection of subjec ts is equi table ; and (3) the 
purposes of the research and the research setting is amenab l e to subjec ts ' we l fa re and p roduc ing desired 
ou tcomes ; that indicat ions of coercion or pre judice are absent , and that par t ic ipat ion is c lear ly voluntary. 
1 In addit ion, the IRB found that you need to orient part ic ipants as fo l lows: (1) s igned in fo rmed consent 
is l equ i ied ; (2) Provis ion is made for collecting, using and storing data in a manne r that protects the 
safety and pr ivacy of the subjects and the conf ident ia l i ty of the data. (3) Appropr ia te safeguards are 
included to protect the rights and welfare of the subjects . 
This project is therefore approved at the Expedi ted Rev iew Level until D e c e m b e r 20, 2005. 
2 Please note that the insti tution is not lesponsible for any actions regarding this pro tocol be fo re 
approva l . If you expand the project at a later date to use other ins t ruments p lease re-apply Copies of 
yout ieques t for human subjects review, your applicat ion, and this approval , are mainta ined in the 
Of f i ce of Sponsored Programs at the above address Please report any changes to this approved 
protocol to this of f icc A Cont inuing Re\ lew protocol will be sent to you in the future to de termine the 
s tatus o f the project . 
Sean R u b m o , M.P.A. 
C o m p l i a n c e M a n a g e r 
Of f i ce of Sponsored Programs 
Western K e n t u c k y Univers i ty 
cc IIS file number Jones HS05-0S7 
c c Shel ley Hicks 
cc Carl ie West 
Sinccreiv. 
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